These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6392595)

  • 1. Immunological study of heart diseases with special reference to the cytotoxicity of the heterophile antibody against cultured myocardial cells.
    Fukuta S; Yamakawa K; Hayashi Y; Iwamoto S; Umemoto S; Kusukawa R; Wada K
    Jpn Circ J; 1984 Dec; 48(12):1354-7. PubMed ID: 6392595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of immunological mechanism in dilated cardiomyopathy.
    Yamakawa K; Fukuta S; Yoshinaga T; Umemoto S; Itagaki T; Kusukawa R
    Jpn Circ J; 1987 Jun; 51(6):665-75. PubMed ID: 3669276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating anti-heart antibodies in heart diseases detected using an immunofluorescent technique.
    Yamakawa K; Fukuta S; Kimura Y; Hayashi Y; Kusukawa R
    Jpn Circ J; 1983 Oct; 47(10):1173-8. PubMed ID: 6195361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different action of xenoreactive natural and immune antibodies on functioning cardiomyocytes.
    Autenrieth A; Müller-Werdan U; Koidl B; Werdan K; Hammer C
    Transplant Proc; 1996 Apr; 28(2):576-7. PubMed ID: 8623281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticardiac antibodies in hypertrophic cardiomyopathy as a marker of severity.
    Maisch B
    Postgrad Med J; 1992; 68 Suppl 1():S29-35. PubMed ID: 1409212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virological study of idiopathic cardiomyopathy: serological study of virus antibodies and immunofluorescent study of myocardial biopsies.
    Kitaura Y
    Jpn Circ J; 1981 Mar; 45(3):279-94. PubMed ID: 6259384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rebound in complement-dependent cytotoxicity and antibody-dependent cell-mediated cytotoxic activity in primate serum after pig liver perfusion.
    Azimzadeh A; Watier H; Meyer C; Guillaumin JM; Beller JP; Kieny R; Zibolt P; Boudjema K; Jaeck D; Cinqualbre J; Wolf P
    Transplant Proc; 1997 Aug; 29(5):2385-6. PubMed ID: 9270774
    [No Abstract]   [Full Text] [Related]  

  • 8. Transplantation immunity of rats induced by hepatoma cells treated with heteroantibody.
    El-Asfahani AM; Maruta H; Mizuno D; Ishidate M; Hashimoto Y; Nishioka K
    Gan; 1975 Feb; 66(1):1-9. PubMed ID: 169181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement-mediated cytotoxic activity of anti-heart antibodies present in the sera of patients with dilated cardiomyopathy.
    Latif N; Smith J; Dunn MJ; Yacoub MH; Rose ML
    Autoimmunity; 1994; 19(2):99-104. PubMed ID: 7772707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterophile antibodies in the sera from renal transplant recipients.
    Akiyama N; Mori T; Kusaba R; Inou T; Kawamura A
    Jpn J Exp Med; 1978 Dec; 48(6):519-24. PubMed ID: 374802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbohydrate-specific human heterophile antibodies in normal human sera that react with xenogeneic cells.
    Laus R; Ulrichs K; Müller-Ruchholtz W
    Int Arch Allergy Appl Immunol; 1988; 85(2):201-7. PubMed ID: 3338860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Removal of anti-Gal alpha (1,3)Gal antibodies diminishes the cytotoxic effect of primate xenoreactive antibodies on rat endothelial cells.
    Azimzadeh A; Anegon I; Thibaudeau K; Charreau B; Zibolt P; Cinqualbre J; Soulillou JP; Wolf P
    Transplant Proc; 1997 Aug; 29(5):2337. PubMed ID: 9270751
    [No Abstract]   [Full Text] [Related]  

  • 13. Problems associated with the presence of immunofluorescent heterophile antibody in sera submitted for autoantibody screening.
    Scott-Morgan L; Lloyd RS
    J Immunol Methods; 1984 Jan; 66(1):69-74. PubMed ID: 6420473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral immunity in cardiomyopathy.
    Lowry PJ; Thompson RA; Littler WA
    Br Heart J; 1983 Oct; 50(4):390-4. PubMed ID: 6354229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibition by alpha-D-galactose of heterophilic antibodies against the antigens of the interstitial connective tissue of the myocardium].
    Danilova TA
    Biull Eksp Biol Med; 1986 May; 101(5):596-8. PubMed ID: 2423154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysis of human tumor cell lines by canine complement plus monoclonal antiganglioside antibodies or natural canine xenoantibodies.
    Helfand SC; Hank JA; Gan J; Sondel PM
    Cell Immunol; 1996 Jan; 167(1):99-107. PubMed ID: 8548851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural antipig xenoantibody is absent in neonatal human serum.
    Xu H; Edwards NM; Chen JM; Dong X; Michler RE
    J Heart Lung Transplant; 1995; 14(4):749-54. PubMed ID: 7578185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody complement-mediated hemolytic studies with kodecytes reveal that human complement utilized in the classical pathway is more stable than generally accepted.
    Perry H; Bovin N; Henry S
    Transfusion; 2016 Oct; 56(10):2495-2501. PubMed ID: 27383738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dilated cardiomyopathy with special reference to humoral immunity.
    Fukuta S; Yoshinaga T; Yamakawa K; Kimura Y; Kusukawa R
    Jpn Circ J; 1992 Oct; 56(10):1073-80. PubMed ID: 1433822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No evidence for αGal epitope transfer from media containing FCS onto human endothelial cells in culture.
    Ramm R; Hartmann T; Tudorache I; Haverich A; Hilfiker A
    Xenotransplantation; 2015; 22(5):345-55. PubMed ID: 26301779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.